Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Shares Outstanding (Diluted Average) (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $205.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 5.14% to $205.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $205.9 million through Nov 2025, up 5.14% year-over-year, with the annual reading at $35.5 million for FY2020, 31.62% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $205.9 million at Cannabis Suisse, up from $203.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $205.9 million in Q4 2025, with the low at $31.1 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $100.5 million, with a median of $70.7 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) dropped 9.88% in 2022, then surged 327.21% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $34.5 million in 2021, then decreased by 9.88% to $31.1 million in 2022, then soared by 47.43% to $45.8 million in 2023, then soared by 327.21% to $195.8 million in 2024, then grew by 5.14% to $205.9 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $205.9 million, $203.5 million, and $70.7 million for Q4 2025, Q3 2025, and Q1 2025 respectively.